Skip to main content

Table 2 Patient baseline characteristics (n = 35)

From: Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

Characteristics

N = 35

Median age (range), years

61 (39–76)

Male/female

27 / 8

ECOG / PS

 

ECOG 0

21

ECOG 1

13

ECOG 2

1

Primary tumor site

 

Gastroesophageal junction

16

Stomach

19

Histology

 

well / moderately differentiated

6

poorly differentiaited / signet- ring cell type

21

Disease status

 

Locally advanced

19

Metastatic

22

Metastatic sites

 

Liver

12

Lymph nodes

11

Peritoneum

4

Lung

5

Bone

2

Other

1

  1. ECOG, Eastern Cooperative Oncology Group.
  2. PS, Performance status.